Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Electron Microscope Shows Atoms 20 Million Times Their Size

By Labmedica staff writers
Posted on 04 Feb 2008
A newly launched electron microscope can show an atom at 20 million times its size, implying that the atom observed would measure approximately 5 mm in diameter.

The new scanning transmission electron microscope, SuperSTEM 2, scans a beam that has been focused down to the size of an atom across a sample providing chemical information on the sample at the same time. More...
Scanning transmission electron microscopy has been used as a technique for some years but detailed imaging of atoms was previously impossible due to defects in lenses. SuperSTEM 2 has an inbuilt computer-controlled system that corrects these defects; the image is sharper and provides elemental and chemical data about atoms and their stability.

Funded by the Engineering and Physical Sciences Research Council (EPSRC; Wiltshire, UK) and led by the University of Liverpool (Liverpool, UK), the SuperSTEM 2 was created by collaboration between the Universities of Liverpool, Glasgow (Glasgow, UK), Leeds (Leeds, UK), and the Daresbury Laboratory (Cheshire, UK). Built on sandstone bedrock, the stable geologic conditions at Daresbury Laboratory, where the SuperSTEM 2 was unveiled, were one of the key reasons for its location. The system is so stable that any sample in the microscope would move no more than 0.5 mm in 100 years or 2000 times slower than continental drift.

Technical director of SuperSTEM 2 at the Daresbury Laboratory, Andrew Bleloch said, "The behavior of atoms can change depending on the size of the particle they are in. SuperSTEM 2 means that researchers can now study how these atoms behave in their ‘native' form and how they might perform as components of different products that come into contact with human beings.”

SuperSTEM also has applications in medicine and is being used to aid in the understanding of diseases such as the inherited disease hemochromatosis, where the liver becomes overloaded with iron. The particles that hold iron within the body are being examined because their structure will shed light on how iron is transported, stored, and released in the body, and the reason they become toxic to the body when there is an iron overload.


Related Links:
Engineering and Physical Sciences Research Council
University of Liverpool
University of Glasgow

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Biochemical Analyzer
iBC 900
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.